Skin and environmental contamination in patients diagnosed with clostridium difficile infection but not meeting clinical criteria for testing

Infection Control and Hospital Epidemiology

Volumn 36, Issue 11, 2015, Pages 1348-1350

  Kundrapu, Sirisha ^a   Sunkesula, Venkata ^a   Tomas, Myreen ^a,b   Donskey, Curtis J ^a,b  

^a CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b LOUIS STOKES CLEVELAND VA MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AGED; ANTIBIOTIC THERAPY; ARTICLE; BACTERIAL SPORE; BACTERIUM CONTAMINATION; CHRONIC CONSTIPATION; CHRONIC DIARRHEA; CLOSTRIDIUM DIFFICILE INFECTION; COLON RESECTION; CONTROLLED STUDY; DIARRHEA; DRUG EXPOSURE; HUMAN; MAJOR CLINICAL STUDY; PEPTOCLOSTRIDIUM DIFFICILE; RECURRENT INFECTION; BACTERIAL SHEDDING; CLOSTRIDIUM INFECTIONS; ISOLATION AND PURIFICATION; LABORATORY TEST; MALE; MICROBIOLOGY; SKIN; STANDARDS;

AGED; BACTERIAL SHEDDING; CLINICAL LABORATORY TECHNIQUES; CLOSTRIDIUM DIFFICILE; CLOSTRIDIUM INFECTIONS; DIARRHEA; ENVIRONMENTAL MICROBIOLOGY; HUMANS; MALE; SKIN; SPORES;

EID: 84958546737     PISSN: 0899823X     EISSN: 15596834     Source Type: Journal    
DOI: 10.1017/ice.2015.191     Document Type: Article

References (10)

1. Cohen SH, Gerding DN, Johnson S, et al. Clinical practice guidelines for Clostridium difficile infection in adults: 2010 update by the Society for Healthcare Epidemiology of America (SHEA) and the Infectious Diseases Society of America (IDSA). Infect Control Hosp Epidemiol 2010;31:431–455.
2. Dubberke ER, Han Z, Bobo L, et al. Impact of clinical symptoms on interpretation of diagnostic assays for Clostridium difficile infections. J Clin Microbiol 2011;49:2887–2893.
3. Kundrapu S, Jury LA, Sitzlar B, Sunkesula VC, Sethi AK, Donskey CJ. Easily modified factors contribute to delays in diagnosis of Clostridium difficile infection: a cohort study and intervention. J Clin Microbiol 2013;51:2365–2370.
4. McDonald LC, Coignard B, Dubberke E, et al. Ad Hoc Clostridium difficile Surveillance Working Group. Recommendations for surveillance of Clostridium difficile–associated disease. Infect Control Hosp Epidemiol 2007;28:140–145.
5. Sethi AK, Al-Nassir WN, Nerandzic MM, Bobulsky GS, Donskey CJ. Persistence of skin contamination and environmental shedding of Clostridium difficile during and after treatment of C. difficile infection. Infect Control Hosp Epidemiol 2010;31: 21–27.
6. Donskey CJ, Kundrapu S, Deshpande A. Colonization versus carriage of Clostridium difficile. Infect Dis Clin North Am 2015;29:13–28.
7. Planche TD, Davies KA, Coen PG, et al. Differences in outcome according to Clostridium difficile testing method: a prospective multicentre diagnostic validation study of C difficile infection. Lancet Infect Dis 2013;13:936–945.
8. Biswas JS, Patel A, Otter JA, van Kleef E, Goldenberg SD. Contamination of the hospital environment from potential Clostridium difficile excretors without active infection. Infect Control Hosp Epidemiol 2015;10:1–3.
9. Peterson LR, Robicsek A. Does my patient have Clostridium difficile infection? Ann Intern Med 2009;151:176–179.
10. Kundrapu S, Sunkesula V, Jury LA, Sitzlar BM, Donskey CJ. Daily disinfection of high-touch surfaces in isolation rooms to reduce contamination of healthcare workers’ hands. Infect Control Hosp Epidemiol 2012;33:1039–1042.